EMYRIA LIMITED - Announcements

12.2%

4.6¢

Market Cap $28.12M

Healthcare Biotechnology

Emyria Limited is an Australia-based early-stage drug development company. The Company is... Emyria Limited is an Australia-based early-stage drug development company. The Company is focused on delivering and developing treatments for mental health and select neurological conditions, guided by real-world data collected with patients across its wholly owned clinical service subsidiaries. Its pipeline comprises MDMA analogue drug development and commercialization of novel serotonin-releasing agents. Its Emyria Healthcare provides evidence-based treatment for patients not finding relief from conventional care, while also helping evaluate emerging new therapies like assisted therapy for post-traumatic stress disorder (PTSD) and assisted therapy for treatment-resistant depression. Its Emyria Data is a robust and ethically sourced real-world data gathered with patients and used to improve its therapy and drug development programs. Its Emyria’s Pipeline includes new psychedelic-assisted therapies and drug treatments for mental health and select neurological diseases.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) to benefit as Denmark commits to cannabis pilot program.

Announcements

Filter Results

All Price Sensitive Only

EMD	Emyria Commences National Expansion with Avive in Brisbane	PRICE SENSITIVE	29/07/25	769.48KB	Share
EMD	June 2025 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	28/07/25	1.84MB	Share
EMD	Update - Proposed issue of securities - EMD		25/07/25	16.2KB	Share
EMD	Update on Bonus Loyalty Options Offer		25/07/25	113.91KB	Share
EMD	Less than Marketable Parcel Sale Facility		18/07/25	393.63KB	Share
EMD	Letter to Shareholders - Notice of General Meeting		18/07/25	267.79KB	Share
EMD	Notice of General Meeting/Proxy Form		18/07/25	493.29KB	Share
EMD	Ceasing to be a substantial holder		30/06/25	334.04KB	Share
EMD	Section 708A(5)(e) Notice		26/06/25	88.41KB	Share
EMD	Application for quotation of securities - EMD		26/06/25	17.61KB	Share
EMD	EMD Presents Medibank Deal to US Psychedelic Conference		20/06/25	2.83MB	Share
EMD	Proposed issue of securities - EMD		18/06/25	27.77KB	Share
EMD	Medibank to Fund Emyria's PTSD Program at Perth Clinic	PRICE SENSITIVE	18/06/25	433.29KB	Share
EMD	Proposed issue of securities - EMD		18/06/25	16.31KB	Share
EMD	Trading Halt	PRICE SENSITIVE	16/06/25	473.05KB	Share
EMD	PTSD Gains Sustained at 6m Follow-Up, MOU Signed with ANU	PRICE SENSITIVE	28/05/25	897.65KB	Share
EMD	Ceasing to be a substantial holder		19/05/25	209.29KB	Share
EMD	Notification of cessation of securities - EMD		14/05/25	13.81KB	Share
EMD	March 2025 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	29/04/25	1.73MB	Share
EMD	Emyria Opens New Empax Centre to Meet Demand and Payer Needs	PRICE SENSITIVE	14/04/25	448.65KB	Share
EMD	Change of Director's Interest Notice - M. Winlo		09/04/25	224.84KB	Share
EMD	Section 708A(5)(e) Notice		31/03/25	88.21KB	Share
EMD	Becoming a substantial holder		31/03/25	108.68KB	Share
EMD	Change of Director's Interest Notice x 2		31/03/25	284.01KB	Share
EMD	Notification regarding unquoted securities - EMD		31/03/25	24.21KB	Share
EMD	Application for quotation of securities - EMD		31/03/25	17.4KB	Share
EMD	Results of Meeting		19/03/25	102.79KB	Share
EMD	Section 708A(5)(e) Notice		05/03/25	88.05KB	Share
EMD	Notification regarding unquoted securities - EMD		05/03/25	22.73KB	Share
EMD	Application for quotation of securities - EMD		05/03/25	16.14KB	Share
EMD	Appendix 4D and Half Year End Financial Report	PRICE SENSITIVE	27/02/25	580.6KB	Share
EMD	Letter to Shareholders - Notice of General Meeting		14/02/25	264.44KB	Share
EMD	Notice of General Meeting/Proxy Form		14/02/25	490.74KB	Share
EMD	Euroz Hartleys 2025 Healthcare Forum Presentation		04/02/25	7.9MB	Share
EMD	Emyria Reports Promising 3-Month PTSD Treatment Results	PRICE SENSITIVE	04/02/25	1.7MB	Share
EMD	December 2024 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	31/01/25	2.12MB	Share
EMD	Leadership Updates	PRICE SENSITIVE	22/01/25	1.24MB	Share
EMD	Section 708A(5)(e) Notice		12/12/24	87.95KB	Share
EMD	Application for quotation of securities - EMD		12/12/24	18.17KB	Share
EMD	Proposed issue of securities - EMD		27/11/24	16.95KB	Share
EMD	Emyria Secures $2.525M in Strongly Supported Placement	PRICE SENSITIVE	27/11/24	575.49KB	Share
EMD	Investor Update - November 2024		25/11/24	4.66MB	Share
EMD	Trading Halt	PRICE SENSITIVE	25/11/24	700.01KB	Share
EMD	Notification of cessation of securities - EMD		15/11/24	13.78KB	Share
EMD	Response to ASX Price Query	PRICE SENSITIVE	12/11/24	968.47KB	Share
EMD	Results of Annual General Meeting		12/11/24	107.04KB	Share
EMD	Proposed issue of securities - EMD		31/10/24	15.93KB	Share
EMD	Emyria & UWA Partner to License Novel Serotonin Therapies	PRICE SENSITIVE	31/10/24	352.8KB	Share
EMD	September 2024 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	30/10/24	1.5MB	Share
EMD	Emyria Gains Ethics Endorsement for Psilocybin Program	PRICE SENSITIVE	28/10/24	459.76KB	Share
EMD	Letter to Shareholders - Notice of Annual General Meeting		11/10/24	266.47KB	Share
EMD	Notice of Annual General Meeting/Proxy Form		11/10/24	481.68KB	Share
EMD	Appendix 4G and Corporate Governance Statement		11/10/24	479.41KB	Share
EMD	Annual Report		11/10/24	5.98MB	Share
EMD	Change of Director's Interest Notice x 2		23/09/24	252.99KB	Share
EMD	Section 708A(5)(e) Notice		20/09/24	87.89KB	Share
EMD	Notification regarding unquoted securities - EMD		20/09/24	15.57KB	Share
EMD	Application for quotation of securities - EMD		20/09/24	16.91KB	Share
EMD	2024 Annual General Meeting - Key Dates		16/09/24	148.96KB	Share
EMD	Hidden Gems Webinar Presentation		06/09/24	5.52MB	Share
EMD	Emyria Shares Interim Success in PTSD Treatment Program	PRICE SENSITIVE	02/09/24	620.03KB	Share
EMD	Appendix 4E & Annual Report for the Year Ended 30 June 2024	PRICE SENSITIVE	30/08/24	1.15MB	Share
EMD	Results of Meeting		21/08/24	106.21KB	Share
EMD	June 2024 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	30/07/24	2.74MB	Share
EMD	Letter to Shareholders - Notice of General Meeting		19/07/24	271.95KB	Share
EMD	Notice of General Meeting/Proxy Form		19/07/24	469.07KB	Share
EMD	Becoming a substantial holder		15/07/24	470.47KB	Share
EMD	Ceasing to be a substantial holder		15/07/24	391.19KB	Share
EMD	Emyria, UWA Secure $499K Grant for MDMA Analogue Program	PRICE SENSITIVE	01/07/24	352.93KB	Share
EMD	Empax Centre Selected As Key Site In Global PTSD Study	PRICE SENSITIVE	20/06/24	459.81KB	Share
EMD	Management Changes		11/06/24	335.02KB	Share
EMD	Change in substantial holding		10/05/24	219.53KB	Share
EMD	Section 708A(5)(e) Notice		07/05/24	87.96KB	Share
EMD	Notification regarding unquoted securities - EMD		07/05/24	18.78KB	Share
EMD	Application for quotation of securities - EMD		07/05/24	18.31KB	Share
EMD	March 2024 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	26/04/24	516.19KB	Share
EMD	Proposed issue of securities - EMD		23/04/24	27.99KB	Share
EMD	Emyria Receives Bids of $2.3M to Expand Clinical Services	PRICE SENSITIVE	23/04/24	674.43KB	Share
EMD	Trading Halt	PRICE SENSITIVE	19/04/24	779.23KB	Share
EMD	Emyria Opens Empax Centre to Advance Mental Health Care	PRICE SENSITIVE	10/04/24	1.92MB	Share
EMD	Emyria Expands Specialist AP Team - First Female for MDMA-AT	PRICE SENSITIVE	05/04/24	449.97KB	Share
EMD	Emyria, Reach Wellness Enter MDMA-AT Research Agreement	PRICE SENSITIVE	03/04/24	688.66KB	Share
EMD	Notification of cessation of securities - EMD		19/03/24	13.77KB	Share
EMD	Response to ASX Aware Query	PRICE SENSITIVE	12/03/24	1014.06KB	Share
EMD	Response to ASX Price Query	PRICE SENSITIVE	08/03/24	962.69KB	Share
EMD	Emyria Half Year Results FY2024		29/02/24	337.57KB	Share
EMD	Appendix 4D and Half Year End Financial Report	PRICE SENSITIVE	28/02/24	979.17KB	Share
EMD	Notification of cessation of securities - EMD		23/02/24	13.89KB	Share
EMD	Webinar Presentation		02/02/24	3.75MB	Share
EMD	December 2023 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	31/01/24	1.26MB	Share
EMD	Notification of cessation of securities - EMD		30/01/24	23.28KB	Share
EMD	Emyria Receives $2.5M R&D Tax Incentive Refund	PRICE SENSITIVE	15/01/24	326.75KB	Share
EMD	Company Overview and Strategic Update		10/01/24	6.18MB	Share
EMD	Emyria Specialist Granted Authorised Prescriber Status	PRICE SENSITIVE	10/01/24	786.2KB	Share
EMD	Change of Director's Interest Notice - M. Winlo		02/01/24	224.73KB	Share
EMD	Change in Substantial Holding		27/11/23	327.97KB	Share
EMD	Notification of cessation of securities - EMD		27/11/23	22.69KB	Share
EMD	Initial Director's Interest Notice - G. Hutchinson		22/11/23	185.03KB	Share
EMD	Final Director's Interest Notice - S. Washer		22/11/23	165.26KB	Share
EMD	Eminent Healthcare Leader New Independent Non-Exec Chair		21/11/23	894.49KB	Share

EMD Emyria Commences National Expansion with Avive in Brisbane
29/07/25	PRICE SENSITIVE	769.48KB	Share
EMD June 2025 Quarterly Activities Report and Appendix 4C
28/07/25	PRICE SENSITIVE	1.84MB	Share
EMD Update - Proposed issue of securities - EMD
25/07/25		16.2KB	Share
EMD Update on Bonus Loyalty Options Offer
25/07/25		113.91KB	Share
EMD Less than Marketable Parcel Sale Facility
18/07/25		393.63KB	Share
EMD Letter to Shareholders - Notice of General Meeting
18/07/25		267.79KB	Share
EMD Notice of General Meeting/Proxy Form
18/07/25		493.29KB	Share
EMD Ceasing to be a substantial holder
30/06/25		334.04KB	Share
EMD Section 708A(5)(e) Notice
26/06/25		88.41KB	Share
EMD Application for quotation of securities - EMD
26/06/25		17.61KB	Share
EMD EMD Presents Medibank Deal to US Psychedelic Conference
20/06/25		2.83MB	Share
EMD Proposed issue of securities - EMD
18/06/25		27.77KB	Share
EMD Medibank to Fund Emyria's PTSD Program at Perth Clinic
18/06/25	PRICE SENSITIVE	433.29KB	Share
EMD Proposed issue of securities - EMD
18/06/25		16.31KB	Share
EMD Trading Halt
16/06/25	PRICE SENSITIVE	473.05KB	Share
EMD PTSD Gains Sustained at 6m Follow-Up, MOU Signed with ANU
28/05/25	PRICE SENSITIVE	897.65KB	Share
EMD Ceasing to be a substantial holder
19/05/25		209.29KB	Share
EMD Notification of cessation of securities - EMD
14/05/25		13.81KB	Share
EMD March 2025 Quarterly Activities Report and Appendix 4C
29/04/25	PRICE SENSITIVE	1.73MB	Share
EMD Emyria Opens New Empax Centre to Meet Demand and Payer Needs
14/04/25	PRICE SENSITIVE	448.65KB	Share
EMD Change of Director's Interest Notice - M. Winlo
09/04/25		224.84KB	Share
EMD Section 708A(5)(e) Notice
31/03/25		88.21KB	Share
EMD Becoming a substantial holder
31/03/25		108.68KB	Share
EMD Change of Director's Interest Notice x 2
31/03/25		284.01KB	Share
EMD Notification regarding unquoted securities - EMD
31/03/25		24.21KB	Share
EMD Application for quotation of securities - EMD
31/03/25		17.4KB	Share
EMD Results of Meeting
19/03/25		102.79KB	Share
EMD Section 708A(5)(e) Notice
05/03/25		88.05KB	Share
EMD Notification regarding unquoted securities - EMD
05/03/25		22.73KB	Share
EMD Application for quotation of securities - EMD
05/03/25		16.14KB	Share
EMD Appendix 4D and Half Year End Financial Report
27/02/25	PRICE SENSITIVE	580.6KB	Share
EMD Letter to Shareholders - Notice of General Meeting
14/02/25		264.44KB	Share
EMD Notice of General Meeting/Proxy Form
14/02/25		490.74KB	Share
EMD Euroz Hartleys 2025 Healthcare Forum Presentation
04/02/25		7.9MB	Share
EMD Emyria Reports Promising 3-Month PTSD Treatment Results
04/02/25	PRICE SENSITIVE	1.7MB	Share
EMD December 2024 Quarterly Activities Report and Appendix 4C
31/01/25	PRICE SENSITIVE	2.12MB	Share
EMD Leadership Updates
22/01/25	PRICE SENSITIVE	1.24MB	Share
EMD Section 708A(5)(e) Notice
12/12/24		87.95KB	Share
EMD Application for quotation of securities - EMD
12/12/24		18.17KB	Share
EMD Proposed issue of securities - EMD
27/11/24		16.95KB	Share
EMD Emyria Secures $2.525M in Strongly Supported Placement
27/11/24	PRICE SENSITIVE	575.49KB	Share
EMD Investor Update - November 2024
25/11/24		4.66MB	Share
EMD Trading Halt
25/11/24	PRICE SENSITIVE	700.01KB	Share
EMD Notification of cessation of securities - EMD
15/11/24		13.78KB	Share
EMD Response to ASX Price Query
12/11/24	PRICE SENSITIVE	968.47KB	Share
EMD Results of Annual General Meeting
12/11/24		107.04KB	Share
EMD Proposed issue of securities - EMD
31/10/24		15.93KB	Share
EMD Emyria & UWA Partner to License Novel Serotonin Therapies
31/10/24	PRICE SENSITIVE	352.8KB	Share
EMD September 2024 Quarterly Activities Report and Appendix 4C
30/10/24	PRICE SENSITIVE	1.5MB	Share
EMD Emyria Gains Ethics Endorsement for Psilocybin Program
28/10/24	PRICE SENSITIVE	459.76KB	Share
EMD Letter to Shareholders - Notice of Annual General Meeting
11/10/24		266.47KB	Share
EMD Notice of Annual General Meeting/Proxy Form
11/10/24		481.68KB	Share
EMD Appendix 4G and Corporate Governance Statement
11/10/24		479.41KB	Share
EMD Annual Report
11/10/24		5.98MB	Share
EMD Change of Director's Interest Notice x 2
23/09/24		252.99KB	Share
EMD Section 708A(5)(e) Notice
20/09/24		87.89KB	Share
EMD Notification regarding unquoted securities - EMD
20/09/24		15.57KB	Share
EMD Application for quotation of securities - EMD
20/09/24		16.91KB	Share
EMD 2024 Annual General Meeting - Key Dates
16/09/24		148.96KB	Share
EMD Hidden Gems Webinar Presentation
06/09/24		5.52MB	Share
EMD Emyria Shares Interim Success in PTSD Treatment Program
02/09/24	PRICE SENSITIVE	620.03KB	Share
EMD Appendix 4E & Annual Report for the Year Ended 30 June 2024
30/08/24	PRICE SENSITIVE	1.15MB	Share
EMD Results of Meeting
21/08/24		106.21KB	Share
EMD June 2024 Quarterly Activities Report and Appendix 4C
30/07/24	PRICE SENSITIVE	2.74MB	Share
EMD Letter to Shareholders - Notice of General Meeting
19/07/24		271.95KB	Share
EMD Notice of General Meeting/Proxy Form
19/07/24		469.07KB	Share
EMD Becoming a substantial holder
15/07/24		470.47KB	Share
EMD Ceasing to be a substantial holder
15/07/24		391.19KB	Share
EMD Emyria, UWA Secure $499K Grant for MDMA Analogue Program
01/07/24	PRICE SENSITIVE	352.93KB	Share
EMD Empax Centre Selected As Key Site In Global PTSD Study
20/06/24	PRICE SENSITIVE	459.81KB	Share
EMD Management Changes
11/06/24		335.02KB	Share
EMD Change in substantial holding
10/05/24		219.53KB	Share
EMD Section 708A(5)(e) Notice
07/05/24		87.96KB	Share
EMD Notification regarding unquoted securities - EMD
07/05/24		18.78KB	Share
EMD Application for quotation of securities - EMD
07/05/24		18.31KB	Share
EMD March 2024 Quarterly Activities Report and Appendix 4C
26/04/24	PRICE SENSITIVE	516.19KB	Share
EMD Proposed issue of securities - EMD
23/04/24		27.99KB	Share
EMD Emyria Receives Bids of $2.3M to Expand Clinical Services
23/04/24	PRICE SENSITIVE	674.43KB	Share
EMD Trading Halt
19/04/24	PRICE SENSITIVE	779.23KB	Share
EMD Emyria Opens Empax Centre to Advance Mental Health Care
10/04/24	PRICE SENSITIVE	1.92MB	Share
EMD Emyria Expands Specialist AP Team - First Female for MDMA-AT
05/04/24	PRICE SENSITIVE	449.97KB	Share
EMD Emyria, Reach Wellness Enter MDMA-AT Research Agreement
03/04/24	PRICE SENSITIVE	688.66KB	Share
EMD Notification of cessation of securities - EMD
19/03/24		13.77KB	Share
EMD Response to ASX Aware Query
12/03/24	PRICE SENSITIVE	1014.06KB	Share
EMD Response to ASX Price Query
08/03/24	PRICE SENSITIVE	962.69KB	Share
EMD Emyria Half Year Results FY2024
29/02/24		337.57KB	Share
EMD Appendix 4D and Half Year End Financial Report
28/02/24	PRICE SENSITIVE	979.17KB	Share
EMD Notification of cessation of securities - EMD
23/02/24		13.89KB	Share
EMD Webinar Presentation
02/02/24		3.75MB	Share
EMD December 2023 Quarterly Activities Report and Appendix 4C
31/01/24	PRICE SENSITIVE	1.26MB	Share
EMD Notification of cessation of securities - EMD
30/01/24		23.28KB	Share
EMD Emyria Receives $2.5M R&D Tax Incentive Refund
15/01/24	PRICE SENSITIVE	326.75KB	Share
EMD Company Overview and Strategic Update
10/01/24		6.18MB	Share
EMD Emyria Specialist Granted Authorised Prescriber Status
10/01/24	PRICE SENSITIVE	786.2KB	Share
EMD Change of Director's Interest Notice - M. Winlo
02/01/24		224.73KB	Share
EMD Change in Substantial Holding
27/11/23		327.97KB	Share
EMD Notification of cessation of securities - EMD
27/11/23		22.69KB	Share
EMD Initial Director's Interest Notice - G. Hutchinson
22/11/23		185.03KB	Share
EMD Final Director's Interest Notice - S. Washer
22/11/23		165.26KB	Share
EMD Eminent Healthcare Leader New Independent Non-Exec Chair
21/11/23		894.49KB	Share

REFRESH

1 2 3 4

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 4.6¢		Change 0.005(12.2%)		Mkt cap ! $28.12M

Open	High	Low	Value	Volume
4.1¢	4.7¢	4.1¢	$420.7K	9.458M

Buyers (Bids)

No.	Vol.	Price($)
4	65675	4.6¢

Sellers (Offers)

Price($)	Vol.	No.
4.7¢	260000	2

View Market Depth

No.	Vol.	Price($)
3	58512	0.046
2	535396	0.045
4	182000	0.044
2	276000	0.043
4	261047	0.042

Price($)	Vol.	No.
0.047	260000	2
0.049	307605	5
0.050	1630211	9
0.051	50000	1
0.054	45740	2

Last trade - 16.10pm 30/07/2025 (20 minute delay)

EMD (ASX) Chart

EMYRIA LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories